Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal publishes innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis also reports on novel therapeutic approaches for promoting or inhibiting angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.
- Publishes articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis
- Presents innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases
- Reports on novel therapeutic approaches for promoting or inhibiting angiogenesis
- Examines new markers and techniques for disease diagnosis and prognosis
Journal information
- Editor-in-Chief
-
- Andrew C. Dudley,
- Arjan W. Griffioen
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 9.780 (2019)
- Impact factor
- 7.338 (2019)
- Five year impact factor
- 24 days
- Submission to first decision
- 112 days
- Submission to acceptance
- 189,928 (2020)
- Downloads
Latest issue
Latest articles
-
-
-
Mechanisms and cell lineages in lymphatic vascular development
Authors (first, second and last of 4)
-
-
SMAD6 transduces endothelial cell flow responses required for blood vessel homeostasis
Authors (first, second and last of 8)
Journal updates
-
Introducing Our New Co-Editor-in-Chief
With great pleasure, we would like to announce that Dr. Andrew Dudley has accepted our invitation to follow on from Prof. Joyce Bischoff as the new co-Editor-in-Chief of the journal. He will work alongside the journal's established Editor Prof. Arjan Griffioen.
-
Editor's Highlights - November 2020
Profs. Arjan Griffioen, Joyce Bischoff and Dr Dudley provide their Editor-in-Chief highlights from this issue.
-
Editor's Highlights - August 2020
Profs. Arjan Griffioen and Joyce Bischoff provide their Editor-in-Chief highlights from this issue.
-
COVID-19 Paper
Angiopoietin-2 is a relevant predictive factor for ICU direct admission in COVID-19 patients. This result showing an endothelial activation reinforces the hypothesis of a COVID-19-associated microvascular dysfunction.
Read for free: https://bit.ly/2XGxmcg
About this journal
- Electronic ISSN
- 1573-7209
- Print ISSN
- 0969-6970
- Abstracted and indexed in
-
- BIOSIS
- Biological Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- EMBiology
- Elsevier Biobase
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Agricultural & Environmental Science Database
- ProQuest Biological Science Database
- ProQuest Biotechnology Research Abstracts
- ProQuest Central
- ProQuest Engineering
- ProQuest Environmental Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Materials Science and Engineering Database
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
